$OXY · OCCIDENTAL PETROLEUM CORP /DE/
Occidental's 10-Q for Q3 FY2026 shows net sales of $6.567B, up 19.0% YoY from $5.519B. Net income attributable to common stockholders was $1.637B ($1.61 diluted EPS) versus $661M ($0.65) a year ago. Nine-month net income reached $8.176B, boosted by $3.099B in discontinued operations from the OxyChem sale to Berkshire Hathaway. Long-term debt fell to $11.625B from $20.623B at year-end 2025, with $10.514B of debt payments made in the nine months.
- Q3 net sales $6.567B, +19.0% YoY from $5.519B.
- Diluted EPS $1.61 vs $0.65 a year earlier.
- Nine-month net income $8.176B, including $3.099B discontinued operations.
- Long-term debt cut to $11.625B from $20.623B at year-end 2025.
- Interest and debt expense fell to $78M from $266M in Q3 2025.
Extended-hours last trade $55.99, up 0.41% vs the $55.76 regular close, a muted reaction to a strong earnings beat.
A 19% revenue jump, near-tripled EPS, and a $9B debt reduction show Occidental's post-OxyChem deleveraging and earnings power.
The OxyChem divestiture to Berkshire Hathaway (closed January 2, 2026) and aggressive debt reduction position Occidental as a deleveraging story among large-cap E&Ps.
Asset impairments and other charges rose to $186M in the nine months from $13M a year earlier. Discontinued operations swung to a $20M loss in Q3 from a $136M gain a year ago.